Watershed AC
Gene-editing technologies
Company Overview
Snapshot
Founded in August 2023, Watershed AC operates with 1–10 employees. The company has secured a grant from the Israel Innovation Authority in May 2024, contributing to its single disclosed funding round.
Business overview
Watershed AC is an Israel-based biotechnology and sustainable aquaculture company specializing in advanced gene-editing technologies, such as CRISPR. The company focuses on improving crustacean traits like growth rate, disease resistance, and environmental adaptation, serving the agriculture and food technologies sector, particularly within Ag Tech and Genetics & Input categories.
Strategic signal
In October 2024, Watershed AC, in collaboration with Evogene and Ben-Gurion University, received approval for a second-year grant. This signals continued validation and support for their gene-editing technology aimed at improving crustacean traits, indicating sustained progress in their R&D efforts and potential for future commercial applications in sustainable aquaculture.
Company Intelligence Q&A
- What is Watershed AC's primary focus?
- Watershed AC focuses on developing and applying advanced gene-editing technologies, such as CRISPR, to enhance crustacean traits like growth rate, disease resistance, and environmental adaptation within the sustainable aquaculture industry.
- When was Watershed AC founded?
- Watershed AC was founded in August 2023.
- Has Watershed AC received any grants?
- Yes, Watershed AC secured a grant from the Israel Innovation Authority in May 2024.
- What was a significant development for Watershed AC in October 2024?
- In October 2024, Watershed AC, Evogene, and Ben-Gurion University received approval for a second-year grant to continue their collaboration on improving crustacean traits using gene-editing technology.
- What is the employee size of Watershed AC?
- Watershed AC currently has 1–10 employees.